Carotid Artery Stenosis Clinical Trial
Official title:
The Embolic Protection With Reverse Flow Study of the GORE Neuro Protection System in Carotid Stenting of Subjects At High Risk for Carotid Endarterectomy
To compare the 30-day safety and efficacy of the GORE Flow Reversal System when used with approved carotid stents to an Objective Performance Criterion derived from distal embolic protection studies.
The GORE Flow Reversal System, manufactured by W. L. Gore & Associates, Inc., was developed
as a proximal occlusion device to reverse the flow of blood in the carotid artery. It is
designed to achieve embolic protection prior to crossing the lesion in the majority of cases
in order to minimize the possibility of an adverse event occurrence.
The objective of this study is to assess the safety and effectiveness of the GORE Flow
Reversal System when used to provide embolic protection during Carotid Artery Stent (CAS)
procedures. Subjects diagnosed with carotid stenosis requiring revascularization and are at
high risk for adverse events from CEA are eligible to participate.
;
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03931161 -
Effect of Evolocumab on Carotid Plaque Composition in Asymptomatic Carotid Artery Stenosis (EVOCAR-1)
|
Phase 4 | |
Recruiting |
NCT03353103 -
Imaging of Unstable Carotid Plaque in Patient Referred to Endarterectomy
|
Phase 2 | |
Completed |
NCT03996148 -
Time to Post-Anesthesia Neurological Evaluation With Three Different Anesthetic Techniques
|
Phase 4 | |
Recruiting |
NCT05968053 -
Detection of Microplastics and Nanoplastics in Neurosurgery Patients (DT-MiNi)
|
||
Completed |
NCT00318851 -
Carotid Artery Stenting With Protection Registry
|
Phase 3 | |
Completed |
NCT00597974 -
Neurological Outcome With Carotid Artery Stenting
|
N/A | |
Active, not recruiting |
NCT05293067 -
Troponin In Carotid Revascularization
|
||
Completed |
NCT03133429 -
Clinical Study to Evaluate the Safety and Effectiveness of MER® Stents in Carotid Revascularisation.
|
N/A | |
Recruiting |
NCT01440036 -
The Correlation Between the Enzyme Paraoxigenase 1 (PON1) to Carotid Artery Atheromatous Plaque
|
N/A | |
Completed |
NCT00417963 -
ViVEXX Carotid Revascularization Trial (VIVA)
|
Phase 3 | |
Completed |
NCT00177346 -
A Randomized Trial of Carotid Artery Stenting With and Without Cerebral Protection
|
N/A | |
Recruiting |
NCT05574972 -
Timing Carotid Stent Clinical Study for the Treatment of Carotid Artery Stenosis(Timing Trial)
|
N/A | |
Recruiting |
NCT02476396 -
Structural Stability of Carotid Plaque and Symptomatology
|
||
Completed |
NCT05451485 -
VFI in Healthy Vessels
|
||
Recruiting |
NCT06033963 -
Safety and Efficacy of Remote Ischemic Conditioning in Patients With Carotid Artery Stenosis Receiving Carotid EndArterectomy
|
N/A | |
Not yet recruiting |
NCT02224209 -
Comparison of Staged Angioplasty and Routine Single-stage Stenting (CAS) in the Treatment of Carotid Artery Stenosis
|
Phase 4 | |
Completed |
NCT02006095 -
Neuroimaging Correlates of Memory Decline Following Carotid Interventions
|
||
Terminated |
NCT01236508 -
Relation of Carotid Artery Plaque Inflammation, Covert Stroke and White Matter Disease
|
Phase 4 | |
Recruiting |
NCT05126238 -
A Lithium-Based Medication to Improve Neurological Outcomes After Surgical Carotid Reconstruction
|
Phase 3 | |
Recruiting |
NCT06170580 -
Improved Image Quality for Assessment of Carotid Artery Stenosis by Ultrafast Ultrasound FLOW Imaging
|